171 related articles for article (PubMed ID: 7682051)
21. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.
Gonias SL; Einarsson M; Pizzo SV
J Clin Invest; 1982 Aug; 70(2):412-23. PubMed ID: 6178757
[TBL] [Abstract][Full Text] [Related]
22. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
23. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
24. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
Booth NA; Anderson JA; Bennett B
J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
[TBL] [Abstract][Full Text] [Related]
25. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
Leebeek FW; Kluft C; Knot EA; Los P; Cohen AF; Six AJ
J Am Coll Cardiol; 1990 May; 15(6):1212-20. PubMed ID: 1691750
[TBL] [Abstract][Full Text] [Related]
26. [Hepatocyte receptors for proteinase inhibitor complexes with plasmin].
Zorin NA; Zhabin SG; Gorin VS
Tsitologiia; 1993; 35(2):55-9. PubMed ID: 7686697
[TBL] [Abstract][Full Text] [Related]
27. Cyclic variation of plasminogen activation in human uterine fluid and the influence of an intrauterine device.
Casslén B; Ohlsson K
Acta Obstet Gynecol Scand; 1981; 60(2):97-101. PubMed ID: 6454324
[TBL] [Abstract][Full Text] [Related]
28. Determination of plasmin-alpha 2-antiplasmin complex in plasma samples by means of a radioimmunoassay.
Wiman B; Jacobsson L; Andersson M; Mellbring G
Scand J Clin Lab Invest; 1983 Feb; 43(1):27-33. PubMed ID: 6194554
[TBL] [Abstract][Full Text] [Related]
29. The plasmin system in human colonic tumors: an immunofluorescence study.
Burtin P; Chavanel G; Andre J
Int J Cancer; 1985 Mar; 35(3):307-14. PubMed ID: 2579035
[TBL] [Abstract][Full Text] [Related]
30. Studies on the effect of plasminogen activator on the interaction between alpha 2-macroglobulin and plasmin.
Toki N; Takasugi S; Sumi H; Yamura T
Thromb Haemost; 1978 Oct; 40(2):377-86. PubMed ID: 83685
[TBL] [Abstract][Full Text] [Related]
31. Plasmin induces acantholysis in skin organ cultures.
Hunziker T; Vassalli JD
Arch Dermatol Res; 1987; 279(5):341-6. PubMed ID: 2957965
[TBL] [Abstract][Full Text] [Related]
32. A chromogenic assay for the detection of plasmin generated by plasminogen activator immobilized on nitrocellulose using a para-nitroanilide synthetic peptide substrate.
Kulisek ES; Holm SE; Johnston KH
Anal Biochem; 1989 Feb; 177(1):78-84. PubMed ID: 2525884
[TBL] [Abstract][Full Text] [Related]
33. Plasminogen activation in bullous pemphigoid immunohistology reveals urokinase type plasminogen activator, its receptor and plasminogen activator inhibitor type-2 in lesional epidermis.
Schaefer BM; Jaeger C; Drepper E; Kramer MD
Autoimmunity; 1996; 23(3):155-64. PubMed ID: 8879451
[TBL] [Abstract][Full Text] [Related]
34. Detection of the plasmin system in human mammary pathology using immunofluorescence.
Clavel C; Chavanel G; Birembaut P
Cancer Res; 1986 Nov; 46(11):5743-7. PubMed ID: 2428483
[TBL] [Abstract][Full Text] [Related]
35. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase.
Toki N; Takasugi S; Ishizu K; Sato H; Sumi H
Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043
[TBL] [Abstract][Full Text] [Related]
36. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
Müllertz S
Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
[TBL] [Abstract][Full Text] [Related]
37. An immunohistochemical study of the distribution of plasminogen and plasminogen activators in bullous pemphigoid.
Venning VA; Wojnarowska F; Cederholm-Williams S
Clin Exp Dermatol; 1993 Mar; 18(2):119-23. PubMed ID: 8481985
[TBL] [Abstract][Full Text] [Related]
38. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
40. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]